Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000262120 refers to a ribosomal protein pseudogene in the human genome. Pseudogenes are genetically similar to known protein-coding genes but typically contain disabling mutations that prevent translation into a functional protein. Most ribosomal protein pseudogenes in the human genome are considered non-functional and are not expressed as proteins[2][3]. While recent studies suggest that some pseudogenes can be transcribed or even translated into peptides, the resultant products, if any, are generally unstable, non-functional, and do not have established biological or disease roles[4]. There is no evidence to suggest that ENSG00000262120 encodes a functional protein, is involved in disease processes, or is a known drug target. Its entry as "60S ribosomal protein pseudogene pseudogene" appears to contain redundant wording and is not considered a valid or actionable therapeutic target under current scientific understanding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60S ribosomal protein pseudogene.